Advertisement
Screener

Aurinia Pharmaceuticals Inc. (AUPH) Pre-Tax Margin

Aurinia Pharmaceuticals Inc. (AUPH) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin 58.62%.
  • 2026-03-31: Pre-Tax Margin 56.53%.
  • 2025-12-31: Pre-Tax Margin 46.28%.
  • 2025-09-30: Pre-Tax Margin 43.50%.

Complete source-backed pre-tax margin history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-3058.62%
2026-03-3156.53%
2025-12-3146.28%
2025-09-3043.50%
2025-06-3031.65%
2025-03-3138.98%
2024-12-311.96%
2024-09-3021.85%
2024-06-302.58%
2024-03-31-19.90%
2023-12-31-58.58%
2023-09-30-24.12%
2023-06-30-29.24%
2023-03-31-74.89%
2022-12-31-88.59%
2022-09-30-14.41%
2022-06-30-125.95%
2022-03-31-173.97%
2021-12-31-139.28%
2021-09-30-342.59%
2021-06-30-709.85%
2021-03-31-5511.05%
2020-12-31-15.82%
2020-09-30-145327.59%
2020-06-30-91524.14%
2020-03-31-87233.33%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-3140.33%
2024-12-313.17%
2023-12-31-44.14%
2022-12-31-79.35%
2021-12-31-395.15%
2020-12-31-205.06%
2019-12-31-27748.74%
2018-12-31-11448.38%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zai Lab Ltd (ZLAB)$2.241B-113.34
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Generate Biomedicines, Inc. (GENB)United States$2.052B